The Australian dollar's surprising resilience in the face of the hit to market sentiment from U.S. tariffs is raising ...

"It's just not playing its game," said Nick Twidale, chief analyst at online broker ATFX, referring to the Aussie, adding ...

President Trump’s approval rating has dipped slightly in new polling just more than two months into his second term. A ...

Compass Therapeutics has announced top-line data from its ongoing COMPANION-002 trial investigating its antibody-based ...

Twenty Academic Affiliates Have Joined Compass Lexecon in the Past Six Months Affiliates Bring Prior Experience at Government Agencies Including the FTC, FCC and SEC Deep Expertise in a Wide Range of ...

The GH Schools, a passion driven Technical Educational Institution, has matriculated some 986 freshmen and women under its ...

COMPASS Pathways plc (NASDAQ:CMPS – Get Free Report) has been given an average rating of “Buy” by the six ratings firms that ...

You can cut through some of the election noise with Vote Compass, which returns for the 2025 federal election. You put in ...

Prominent economist Oren Cass is facing criticism for his long history of criticizing both Elon Musk's DOGE efforts and ...

Manhattan apartment sales rose 29% in the first quarter, and the total value of apartment sales in the city reached $5.7 ...

Wedbush reiterated their outperform rating on shares of Compass Therapeutics (NASDAQ:CMPX – Free Report) in a report ...

Stifel raised the firm’s price target on Compass Therapeutics (CMPX) to $11 from $10 and keeps a Buy rating on the shares. The firm reiterated ...